Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Weiss, J.M., Csoszi, T., Maglakelidze, M., Hoyer, R.J., Beck, J.T., Domine Gomez, M., Lowczak, A., Aljumaily, R., Rocha Lima, C.M., Boccia, R.V., Hanna, W., Nikolinakos, P., Chiu, V.K., Owonikoko, T.K., Schuster, S.R., Hussein, M.A., Richards, D.A., Sawrycki, P., Bulat, I., Hamm, J.T., Hart, L.L., Adler, S., Antal, J.M., Lai, A.Y., Sorrentino, J.A., Yang, Z., Malik, R.K., Morris, S.R., Roberts, P.J., Dragnev, K.H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Kindler, H.L., Richards, D.A., Garbo, L.E., Garon, E.B., Stephenson, J.J., Rocha-Lima, C.M., Safran, H., Chan, D., Kocs, D.M., Galimi, F., McGreivy, J., Bray, S.L., Hei, Y., Feigal, E.G., Loh, E., Fuchs, C.S.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma
Marsh, Robert de W, Rocha Lima, C M, Levy, D E, Mitchell, E P, Rowland, Jr, K M, Benson, 3rd, A B
Published in American journal of clinical oncology (01.02.2007)
Published in American journal of clinical oncology (01.02.2007)
Get more information
Journal Article
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
Rocha-Lima, C.M., Herndon, J.E., Lee, M.E., Atkins, J.N., Mauer, A., Vokes, E., Green, M.R.
Published in Annals of oncology (01.02.2007)
Published in Annals of oncology (01.02.2007)
Get full text
Journal Article
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer
Wolpin, B.M., O'Reilly, E.M., Ko, Y.J., Blaszkowsky, L.S., Rarick, M., Rocha-Lima, C.M., Ritch, P., Chan, E., Spratlin, J., Macarulla, T., McWhirter, E., Pezet, D., Lichinitser, M., Roman, L., Hartford, A., Morrison, K., Jackson, L., Vincent, M., Reyno, L., Hidalgo, M.
Published in Annals of oncology (01.07.2013)
Published in Annals of oncology (01.07.2013)
Get full text
Journal Article
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy
Garrett, C R, Siu, L L, El-Khoueiry, A, Buter, J, Rocha-Lima, C M, Marshall, J, LoRusso, P, Major, P, Chemidlin, J, Mokliatchouk, O, Velasquez, L, Hayes, W, Feltquate, D, Syed, S, Ford, S, Kollia, G, Galbraith, S, Nuyten, D S A
Published in British journal of cancer (28.06.2011)
Published in British journal of cancer (28.06.2011)
Get full text
Journal Article
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
Rocha Lima, C. M., Rizvi, N. A., Zhang, C., Herndon, J. E., Crawford, J., Govindan, R., King, G. W., Green, M. R.
Published in Annals of oncology (01.03.2004)
Published in Annals of oncology (01.03.2004)
Get full text
Journal Article
Leishmania infantum infection rate in dogs housed in open-admission shelters is higher than of domiciled dogs in an endemic area of canine visceral leishmaniasis. Epidemiological implications
Estevam, Letícia G.T.M., Veloso, Laura B., Silva, Geralda G., Mori, Carina C., Franco, Paula F., Lima, Ana C.V.M. Rocha, Ássimos, Gabriela R., Reis, Ilka A., Andrade-Filho, José D., Araújo, Márcio S.S., Ribeiro, Vitor M., Almeida, Ana P.M.M., Paz, Gustavo F.
Published in Acta tropica (01.08.2022)
Published in Acta tropica (01.08.2022)
Get full text
Journal Article
Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancer
Rocha Lima, C M, Eckardt, J R, Leong, S S, Sherman, C A, Perkel, J A, Putman, T, Safa, A R, Bahadori, H R, Green, M R
Published in Seminars in oncology (01.10.1999)
Get more information
Published in Seminars in oncology (01.10.1999)
Journal Article
EUS-FNA with rescue FISH for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology
Akunyili, I. I., Rocha Lima, C. M. S., Macintyre, J., Solis, N., Merchan, J. R., Sleeman, D., Levi, J. U., Ribeiro, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Weiss, J M, Csoszi, T, Maglakelidze, M, Hoyer, R J, Beck, J T, Domine Gomez, M, Lowczak, A, Aljumaily, R, Rocha Lima, C M, Boccia, R V, Hanna, W, Nikolinakos, P, Chiu, V K, Owonikoko, T K, Schuster, S R, Hussein, M A, Richards, D A, Sawrycki, P, Bulat, I, Hamm, J T, Hart, L L, Adler, S, Antal, J M, Lai, A Y, Sorrentino, J A, Yang, Z, Malik, R K, Morris, S R, Roberts, P J, Dragnev, K H
Published in Annals of oncology (01.10.2019)
Get full text
Published in Annals of oncology (01.10.2019)
Journal Article
Phase I trial of weekly and every 3 weeks ixabepilone (Ix) and sunitinib (S) in advanced solid tumors (STs)
Kittaneh, M., Montero, A. J., Kovacs, K., Guardiola Amado, V. D., Flores, A. M., Ferrell, A., Vulfovich, M., Pegram, M. D., Benedetto, P. W., Rocha Lima, C. M. S., Merchan, J. R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Combination study of navitoclax with gemcitabine (G) in patients (pts) with solid tumors
Cleary, J. M., Rocha Lima, C. M. S., Hurwitz, H., Montero, A. J., Shapiro, G., Franklin, C., Yang, J., Graham, A. M., Busman, T., Mabry, M., Holen, K. D., Krivoshik, A., Humerickhouse, R., Uronis, H.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with. G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC)
Wolpin, B. M., O'Reilly, E. M., Ko, Y., Blaszkowsky, L. S., Rarick, M. U., Rocha Lima, C. M. S., Ritch, P. S., Chan, E., Spratlin, J. L., Macarulla, T., McWhirter, E., Pezet, D., Lichinitser, M., Roman, L. D., Hartford, A., Jackson, L., Vincent, M., Reyno, L. M., Hidalgo, M.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Does delay of adjuvant chemotherapy affect the clinical outcome in patients with colon cancer?
Bayraktar, U. D., Bayraktar, S., Herna, S., Ku, N., Jones, C., Merchan, J., Sands, L. R., Marchetti, F., Montero, A., Rocha-Lima, C. M.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Gemcitabine and oxaliplatin (GEMOX), a promissing combination for the treatment of relapsed, advanced or metastatic non small cell lung cancer (NSCLC)
Calfa, C. J., Raez, L. E., Lopes, G., Walker, G., Farfan, N., Macintyre, J., Blaya, M., Rocha-Lima, C. M.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Radiaton pneumonitis with the combination of irinotecan and carboplatin concomitantly with radiation for stage III non-small cell lung cancer
Raez, L. E., Hatoum, G., Bastos, B. R., Walker, G., Tolba, K., Farfan, N., Karr, M., Kobina, S., Rodriguez, V., Rocha-Lima, C. M.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article